BR112016001774A2 - métodos de preparação de ribosídeo de nicotinamida e seus derivados - Google Patents

métodos de preparação de ribosídeo de nicotinamida e seus derivados

Info

Publication number
BR112016001774A2
BR112016001774A2 BR112016001774A BR112016001774A BR112016001774A2 BR 112016001774 A2 BR112016001774 A2 BR 112016001774A2 BR 112016001774 A BR112016001774 A BR 112016001774A BR 112016001774 A BR112016001774 A BR 112016001774A BR 112016001774 A2 BR112016001774 A2 BR 112016001774A2
Authority
BR
Brazil
Prior art keywords
substituted
unsubstituted
derivatives
nicotinamide riboside
preparation methods
Prior art date
Application number
BR112016001774A
Other languages
English (en)
Other versions
BR112016001774B1 (pt
BR112016001774A8 (pt
Inventor
CROSSEY Kerri
Migaud Marie
Doherty Mark
Redpath Philip
Original Assignee
Univ Belfast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Belfast filed Critical Univ Belfast
Publication of BR112016001774A2 publication Critical patent/BR112016001774A2/pt
Publication of BR112016001774A8 publication Critical patent/BR112016001774A8/pt
Publication of BR112016001774B1 publication Critical patent/BR112016001774B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048Pyridine radicals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

a invenção refere-se a métodos de preparação do ribosídeo de nicotinamida e seus derivados. por um lado, a invenção se refere a um método de preparação de um composto de fórmula (i), onde n é 0 ou 1; m é 0 ou 1; y é o ou s; r1 é selecionado de h, alquil substituído ou não substituído, alqueno substituído ou não substituído, alquenil substituído ou não substituído, aril substituído ou não substituído, amino primário ou secundário substituído ou não substituído e azido substituído ou não substituído; r2-r5, que podem ser iguais ou diferentes, são cada um selecionado independentemente a partir de h, alquil substituído ou não substituído, alquenil substituído ou não substituído, alquenil substituído ou não substituído e aril substituído ou não substituído; e x– é um ânion, selecionado a partir de um ânion de um ácido carboxílico substituído ou não substituído, um haleto, um sulfonato substituído ou não substituído, um fosfato substituído ou não substituído, um sulfato substituído ou não substituído, um carbonato substituído ou não substituído e um carbamato substituído ou não substituído.
BR112016001774-9A 2013-07-29 2014-07-24 Método para o preparo de um composto BR112016001774B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1313465.5A GB201313465D0 (en) 2013-07-29 2013-07-29 Methods of preparing nicotinamide riboside and derivatives thereof
GB1313465.5 2013-07-29
PCT/EP2014/065971 WO2015014722A1 (en) 2013-07-29 2014-07-24 Methods of preparing nicotinamide riboside and derivatives thereof

Publications (3)

Publication Number Publication Date
BR112016001774A2 true BR112016001774A2 (pt) 2017-08-01
BR112016001774A8 BR112016001774A8 (pt) 2020-01-21
BR112016001774B1 BR112016001774B1 (pt) 2021-06-22

Family

ID=49167061

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016001774-9A BR112016001774B1 (pt) 2013-07-29 2014-07-24 Método para o preparo de um composto

Country Status (14)

Country Link
US (5) US10000519B2 (pt)
EP (2) EP3321274A1 (pt)
JP (1) JP6208352B2 (pt)
KR (2) KR102303966B1 (pt)
CN (2) CN108707174A (pt)
AU (4) AU2014298629B2 (pt)
BR (1) BR112016001774B1 (pt)
CA (2) CA3192957A1 (pt)
ES (1) ES2652654T3 (pt)
GB (1) GB201313465D0 (pt)
HK (2) HK1218918A1 (pt)
MX (1) MX349969B (pt)
WO (1) WO2015014722A1 (pt)
ZA (1) ZA201802315B (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201313465D0 (en) 2013-07-29 2013-09-11 Queens University Of The Belfast Methods of preparing nicotinamide riboside and derivatives thereof
CA2950727A1 (en) * 2014-06-02 2015-12-10 Glaxosmithkline Intellectual Property (No.2) Limited Preparation and use of crystalline beta-d-nicotinamide riboside
WO2015186114A1 (en) * 2014-06-06 2015-12-10 Glaxosmithkline Intellectual Property (No.2) Limited Nicotinamide riboside analogs and pharmaceutical compositions and uses thereof
CN106715454B (zh) * 2014-07-24 2020-06-16 格雷斯公司 烟酰胺核苷的结晶形式
BR112017019409A2 (pt) * 2015-03-09 2018-04-24 Grace W R & Co forma cristalina de ribosídeo de nicotinamida
MX2017011851A (es) * 2015-03-16 2018-04-11 Chromadex Inc Composiciones de acido nicotinico ribosido o de nicotinamida ribosido, derivados reducidos de los mismos, y su uso.
US10392414B2 (en) 2015-07-15 2019-08-27 Cornell University Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives
EP3331894B1 (en) 2015-08-05 2021-02-17 Metro International Biotech, LLC Nicotinamide mononucleotide derivatives and their uses
GB2542881B (en) 2015-10-02 2020-01-01 Carr Andrew Crystal forms of ß-nicotinamide mononucleotide
WO2017079195A1 (en) * 2015-11-02 2017-05-11 Mitobridge, Inc. Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases
US11248018B2 (en) 2016-02-23 2022-02-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Process for preparation of nicotinamide riboside (NR) and cosmetic composition comprising (NR and a phosphate-binding agent
EP3429354A4 (en) 2016-03-16 2020-03-25 Chromadex Inc. B-VITAMIN AND AMINO ACID CONJUGATES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, DERIVATIVES THEREOF AND METHOD FOR THE PRODUCTION THEREOF
NZ747693A (en) 2016-04-20 2023-07-28 Chromadex Inc Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as nad+increasing precursors
WO2017218580A1 (en) 2016-06-14 2017-12-21 Rejuvenation Therapeutics Corporation Synthetic methods for the preparation of nicotinamide riboside and related compounds
GB2553001A (en) * 2016-08-19 2018-02-21 The Queen's Univ Of Belfast Lactone intermediates of nicotinamide riboside and nicotinate riboside
US9975915B1 (en) * 2016-11-11 2018-05-22 The Queen's University Of Belfast Crystalline forms of nicotinoyl ribosides, modified derivatives thereof, and phosphorylated analogs thereof, and methods of preparation thereof
CA3044814A1 (en) 2016-11-29 2018-06-07 Charles M. Brenner Use of nad precursors for improving maternal health and/or offspring health
US11071747B2 (en) 2016-11-29 2021-07-27 University Of Iowa Research Foundation Use of NAD precursors for breast enhancement
US11286274B2 (en) 2017-06-19 2022-03-29 Mitopower Llc Nicotinamide riboside derivatives and their uses
WO2019006262A1 (en) * 2017-06-30 2019-01-03 Elysium Health, Inc. METHODS OF SYNTHESIZING NICOTINAMIDE RIBOSIDE
CN112020363A (zh) 2017-12-22 2020-12-01 益力舒健康公司 烟酰胺核苷氯化物的结晶形式
WO2019122084A1 (en) 2017-12-22 2019-06-27 Stemtek Therapeutics, S.L. Process for the preparation of nicotinamide riboside chloride derivatives
US11180521B2 (en) 2018-01-30 2021-11-23 Metro International Biotech, Llc Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof
CN110283221A (zh) * 2018-03-19 2019-09-27 药源药物化学(上海)有限公司 杂环化合物的制备和纯化方法
CN110452277A (zh) * 2018-05-07 2019-11-15 明特奇点医疗科技(成都)有限公司 一种烟酰胺核糖的制备方法
CN113490675A (zh) * 2018-05-22 2021-10-08 江普斯塔特生育有限公司 作为抗衰老剂的烟酸核苷的氨基酸盐
CN108774278A (zh) * 2018-09-10 2018-11-09 张洪喜 一种制备尼克酰胺核苷盐的方法
KR102060374B1 (ko) * 2018-12-14 2019-12-30 주식회사 휴메딕스 지방알코올 컨쥬게이션된 니코틴아미드 리보사이드 유도체
EP3897666A2 (en) 2018-12-17 2021-10-27 Mitopower LLC Nicotinyl riboside compounds and their uses
US11939348B2 (en) 2019-03-22 2024-03-26 Metro International Biotech, Llc Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide
US10618927B1 (en) 2019-03-22 2020-04-14 Metro International Biotech, Llc Compositions and methods for modulation of nicotinamide adenine dinucleotide
US20220324899A1 (en) * 2019-08-14 2022-10-13 Metro International Biotech, Llc Compounds and compositions for differential modulation of nicotinamide adenine dinucleotide
CN110642897B (zh) * 2019-09-27 2021-04-06 武汉一若生物材料有限公司 一种β-烟酰胺核糖氯化物的制备方法
CN110658224B (zh) * 2019-10-15 2022-11-22 中国中医科学院中药研究所 一种氢核磁定量分析技术测定nmn绝对含量的方法
CN111153953A (zh) * 2020-01-07 2020-05-15 杭州洁汉化工有限公司 一种烟酰胺核糖氯化物的高效合成方法
CN111454311B (zh) * 2020-04-03 2021-10-19 深圳市迪克曼科技开发有限公司 烟酰胺核糖的有机酸盐及其组合物与制备方法
CN111647032B (zh) * 2020-06-29 2023-02-24 上海舒泽生物科技研究所 一种β-烟酰胺单核苷酸的合成方法
CN111848710A (zh) * 2020-08-20 2020-10-30 深圳市迪克曼科技开发有限公司 烟酰胺核糖及其还原态、盐的制备方法
US20230271995A1 (en) * 2020-09-15 2023-08-31 Societe Des Produits Nestle S.A. Methods for producing dihydronicotinamide riboside from nicotinamide riboside chloride
CN112851730B (zh) * 2021-01-08 2023-02-21 厦门瑞林药业有限公司 一种nmn中间体nr氯化物合成方法
JP2024517260A (ja) 2021-05-04 2024-04-19 ボーハン アンド カンパニー エーエス ニコチンアミドリボシドクロリド(nrcl)の合成プロセス
WO2022251491A1 (en) 2021-05-27 2022-12-01 Metro International Biotech, Llc Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use
WO2023166160A1 (en) 2022-03-04 2023-09-07 Bohan & Co As. Process for synthesis of 1,4-dihydronicotinamide riboside (nrh) from nicotinamide-beta-riboside triacetate chloride (nra-cl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540263A1 (en) * 1991-10-23 1993-05-05 Cancer Research Campaign Technology Limited Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form
US6689760B1 (en) * 2000-07-10 2004-02-10 Enzrel Inc. Anti-mycobacterial compositions
EP3369738B1 (en) * 2005-11-18 2020-05-20 Cornell Research Foundation, Inc. Method for making nicotinoyl ribosides and nicotinamide beta-riboside
US9603862B2 (en) 2009-12-14 2017-03-28 Cornell University Activation and activators of SIRT5
GB201313465D0 (en) 2013-07-29 2013-09-11 Queens University Of The Belfast Methods of preparing nicotinamide riboside and derivatives thereof

Also Published As

Publication number Publication date
CA2918955A1 (en) 2015-02-05
EP3321274A1 (en) 2018-05-16
ES2652654T3 (es) 2018-02-05
MX2016001211A (es) 2016-10-28
US11981698B2 (en) 2024-05-14
HK1218918A1 (zh) 2017-03-17
US10000519B2 (en) 2018-06-19
CN105636973B (zh) 2018-06-01
MX349969B (es) 2017-08-23
AU2020201254B2 (en) 2022-05-26
WO2015014722A1 (en) 2015-02-05
AU2014298629A1 (en) 2016-02-11
US20160168184A1 (en) 2016-06-16
JP6208352B2 (ja) 2017-10-04
KR102414886B1 (ko) 2022-07-01
KR20160043974A (ko) 2016-04-22
AU2018211238A1 (en) 2018-08-16
HK1255037A1 (zh) 2019-08-02
KR102303966B1 (ko) 2021-09-24
CN105636973A (zh) 2016-06-01
US11584770B2 (en) 2023-02-21
NZ716277A (en) 2021-03-26
AU2020201254A1 (en) 2020-03-12
AU2014298629B2 (en) 2018-08-16
EP3027635B1 (en) 2017-09-20
JP2016530248A (ja) 2016-09-29
US20240101588A1 (en) 2024-03-28
KR20210038718A (ko) 2021-04-07
GB201313465D0 (en) 2013-09-11
AU2022203196B2 (en) 2023-11-23
US20200291055A1 (en) 2020-09-17
CA2918955C (en) 2023-05-09
US20180186824A1 (en) 2018-07-05
ZA201802315B (en) 2023-02-22
CA3192957A1 (en) 2015-02-05
AU2022203196A1 (en) 2022-06-02
US10815262B2 (en) 2020-10-27
EP3027635A1 (en) 2016-06-08
BR112016001774B1 (pt) 2021-06-22
BR112016001774A8 (pt) 2020-01-21
US20220259250A1 (en) 2022-08-18
CN108707174A (zh) 2018-10-26

Similar Documents

Publication Publication Date Title
BR112016001774A2 (pt) métodos de preparação de ribosídeo de nicotinamida e seus derivados
BR112017025969A2 (pt) métodos, e métodos para produzir monofosfato de tiaminila, de piridoxila, de adenosila, ou um sal dos mesmos
CY1124537T1 (el) Παραγωγο πυριδονης που εχει τετραϋδροπυρανυλ μεθυλ ομαδα
CY1118435T1 (el) Παραγωγο μορφολινο νουκλεϊνικου οξεος
EA201591503A1 (ru) Производные нафтиридина, полезные в качестве антагонистов альфа-v-бета-6 интегрина
MY176803A (en) Polymorph of syk inhibitors
CY1119220T1 (el) Μονοκυκλικο παραγωγο πυριδινης
EA201500875A1 (ru) СОЛИ ПРОИЗВОДНЫХ 2-АМИНО-1-ГИДРОКСИЭТИЛ-8-ГИДРОКСИХИНОЛИН-2-(1Н)-ОНА, ОБЛАДАЮЩИЕ АГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К β2 АДРЕНЕРГИЧЕСКОМУ РЕЦЕПТОРУ И АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К МУСКАРИНОВОМУ РЕЦЕПТОРУ М3
MX2015016513A (es) Bisulfato del inhibidor de la janus quinasa (jak) y metodo de preparacion para el mismo.
MX2017014661A (es) Proceso para la preparacion de triazinas.
PH12014501711A1 (en) Benzyl sulfonamide derivatives useful as mogat-2 inhibitors
BR112015019437A2 (pt) complexo de bis(2-indenil) metaloceno
BR112021026899A2 (pt) Compostos heterocíclicos
MX2018003047A (es) Metodo para producir sales de biguanida y s-triazinas.
BR112018001255A2 (pt) composto direcionado à il-23a e fator de ativação de células b (baff) e seus usos
WO2016142819A3 (en) Novel process for the preparation of ranolazine
TR201819440T4 (tr) Yüklü çapraz bağlayıcıların hazırlanmasına yönelik yöntemler.
CY1115372T1 (el) Συνθεσεις δεσοξυχολικου οξεος και αλατα αυτου
BR112015029589A2 (pt) compostos de amônio quaternário e composições inibidoras de hidrato de gás
CY1114704T1 (el) Κρυσταλλικη μορφη δ του αλατος αργινινης της περινδοπριλης, μεθοδος παρασκευης της και φαρμακευτικες συνθεσεις οι οποιες την περιεχουν
AR098397A1 (es) Proceso de fluoración de compuestos
CL2018001961A1 (es) Procedimiento de preparación de derivados de metil-penam (divisional solicitud 201602880)
MY186396A (en) Xanthine derivative
CY1116826T1 (el) Μεθοδος ενζυματικης συνθεσης toy (7s) 3,4-ιμεθοξυδικυκλο[4.2.0]οκτα- 1,3,5-τριενο-7-καρβοξυλικου οξεος και εφαρμογη στην συνθεση της ιβαμπραδινης και των αλατων αυτης
EA201400882A1 (ru) Способ стереоселективного синтеза 9-гидрокси-5-оксо-1,4-диазаспиро[5.5]ундеканов, содержащих защитные группы в 1,4-положениях

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/07/2014, OBSERVADAS AS CONDICOES LEGAIS.